176 related articles for article (PubMed ID: 18295332)
1. Antibodies to CD1d enhance thymic expression of invariant NKT TCR and increase the presence of NOD thymic invariant NKT cells.
White TC; Chauhan V; Middlebrook AJ; Im JS; Deluca D
Dev Comp Immunol; 2008; 32(8):943-56. PubMed ID: 18295332
[TBL] [Abstract][Full Text] [Related]
2. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
[TBL] [Abstract][Full Text] [Related]
3. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
[TBL] [Abstract][Full Text] [Related]
4. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets.
Naumov YN; Bahjat KS; Gausling R; Abraham R; Exley MA; Koezuka Y; Balk SB; Strominger JL; Clare-Salzer M; Wilson SB
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13838-43. PubMed ID: 11707602
[TBL] [Abstract][Full Text] [Related]
5. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
[TBL] [Abstract][Full Text] [Related]
6. Examining the role of CD1d and natural killer T cells in the development of nephritis in a genetically susceptible lupus model.
Yang JQ; Wen X; Liu H; Folayan G; Dong X; Zhou M; Van Kaer L; Singh RR
Arthritis Rheum; 2007 Apr; 56(4):1219-33. PubMed ID: 17393451
[TBL] [Abstract][Full Text] [Related]
7. Control of NKT cell differentiation by tissue-specific microenvironments.
Yang Y; Ueno A; Bao M; Wang Z; Im JS; Porcelli S; Yoon JW
J Immunol; 2003 Dec; 171(11):5913-20. PubMed ID: 14634102
[TBL] [Abstract][Full Text] [Related]
8. CD1d-specific NK1.1+ T cells with a transgenic variant TCR.
Sköld M; Faizunnessa NN; Wang CR; Cardell S
J Immunol; 2000 Jul; 165(1):168-74. PubMed ID: 10861049
[TBL] [Abstract][Full Text] [Related]
9. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
[TBL] [Abstract][Full Text] [Related]
10. A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage.
Pellicci DG; Hammond KJ; Uldrich AP; Baxter AG; Smyth MJ; Godfrey DI
J Exp Med; 2002 Apr; 195(7):835-44. PubMed ID: 11927628
[TBL] [Abstract][Full Text] [Related]
11. Prevention of type 1 diabetes by invariant NKT cells is independent of peripheral CD1d expression.
Novak J; Beaudoin L; Park S; Griseri T; Teyton L; Bendelac A; Lehuen A
J Immunol; 2007 Feb; 178(3):1332-40. PubMed ID: 17237379
[TBL] [Abstract][Full Text] [Related]
12. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor.
Borg NA; Wun KS; Kjer-Nielsen L; Wilce MC; Pellicci DG; Koh R; Besra GS; Bharadwaj M; Godfrey DI; McCluskey J; Rossjohn J
Nature; 2007 Jul; 448(7149):44-9. PubMed ID: 17581592
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-4 but not interleukin-10 protects against spontaneous and recurrent type 1 diabetes by activated CD1d-restricted invariant natural killer T-cells.
Mi QS; Ly D; Zucker P; McGarry M; Delovitch TL
Diabetes; 2004 May; 53(5):1303-10. PubMed ID: 15111500
[TBL] [Abstract][Full Text] [Related]
14. CD1d-independent developmental acquisition of prompt IL-4 gene inducibility in thymus CD161(NK1)-CD44lowCD4+CD8- T cells is associated with complementarity determining region 3-diverse and biased Vbeta2/Vbeta7/Vbeta8/Valpha3.2 T cell receptor usage.
Chen YT; Kung JT
J Immunol; 2005 Nov; 175(10):6537-50. PubMed ID: 16272308
[TBL] [Abstract][Full Text] [Related]
15. Subcongenic analysis of genetic basis for impaired development of invariant NKT cells in NOD mice.
Chen YG; Driver JP; Silveira PA; Serreze DV
Immunogenetics; 2007 Sep; 59(9):705-12. PubMed ID: 17619875
[TBL] [Abstract][Full Text] [Related]
16. Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice.
Poulton LD; Smyth MJ; Hawke CG; Silveira P; Shepherd D; Naidenko OV; Godfrey DI; Baxter AG
Int Immunol; 2001 Jul; 13(7):887-96. PubMed ID: 11431419
[TBL] [Abstract][Full Text] [Related]
17. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
Eberl G; Lees R; Smiley ST; Taniguchi M; Grusby MJ; MacDonald HR
J Immunol; 1999 Jun; 162(11):6410-9. PubMed ID: 10352254
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic defects in the T-cell lineage results in natural killer T-cell deficiency and the development of diabetes in the nonobese diabetic mouse.
Yang Y; Bao M; Yoon JW
Diabetes; 2001 Dec; 50(12):2691-9. PubMed ID: 11723051
[TBL] [Abstract][Full Text] [Related]
19. Targeted expression of human CD1d in transgenic mice reveals independent roles for thymocytes and thymic APCs in positive and negative selection of Valpha14i NKT cells.
Schümann J; Pittoni P; Tonti E; Macdonald HR; Dellabona P; Casorati G
J Immunol; 2005 Dec; 175(11):7303-10. PubMed ID: 16301636
[TBL] [Abstract][Full Text] [Related]
20. Role of regulatory invariant CD1d-restricted natural killer T-cells in protection against type 1 diabetes.
Hussain S; Wagner M; Ly D; Delovitch TL
Immunol Res; 2005; 31(3):177-88. PubMed ID: 15888910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
